[1]
A. M. Morosanu, “New onset severe ulcerative colitis following Ixekizumab therapy”, Arch Clin Cases, vol. 9, no. 4, pp. Arch Clin Cases 2022; 9(4):173–176, Dec. 2022, doi: 10.22551/2022.37.0904.10227.